State Street’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

State Street’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-40,960	Closed	-$158K	–	4652
2023 Q2	$158K	Hold	40,960	–	–	﹤0.01%	4076
2023 Q1	$124K	Buy	40,960 +5,800	+16%	+$20K	﹤0.01%	4255
2022 Q4	$72.1K	Buy	35,160 +18,000	+105%	+$54.8K	﹤0.01%	4462
2022 Q3	$59K	Hold	17,160	–	–	﹤0.01%	4622
2022 Q2	$72K	Buy	17,160 +900	+6%	+$2.13K	﹤0.01%	4643
2022 Q1	$49K	Buy	16,260 +560	+4%	+$2.15K	﹤0.01%	4799
2021 Q4	$73K	Hold	15,700	–	–	﹤0.01%	4639
2021 Q3	$121K	Buy	+15,700	New	+$120K	﹤0.01%	4497
2021 Q2	–	Sell	-58,218	Closed	-$661K	–	4501
2021 Q1	$661K	Buy	+58,218	New	+$913K	﹤0.01%	3699

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

State Street's DBTX Position: Q3 2023 in Review

State Street sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 40,960 shares — an estimated $158K sold.

State Street first reported a position in DBTX in Q1 2021 and held it in 9 quarters. The position peaked at $661K in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

State Street reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
State Street sold 40,960 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $158K.
State Street first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
State Street's Decibel Therapeutics, Inc. Common Stock position peaked at $661K in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.